Biogen Idec (BIIB) Pops on Strong Tecfidera Rx Growth
Biogen Idec (Nasdaq: BIIB) is ticking higher on the session following an update on Tecfidera (BG-12) performance.
Data out ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Data out ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)